Label: HYDROSEPTINE- zinc oxide, menthol ointment
- NDC Code(s): 71399-6743-1
- Packager: AKRON PHARMA INC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated March 10, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredients
- Uses
- Warnings
- Stop use and ask doctor if
- Keep out of reach of children.
- Directions
-
Inactive Ingredients:
Other information store at room temperature 15-30 C (59-86 F)
Inactive ingredients calamine, chlorothymol, glycerin, lanoline,phenol, sodium bicarbonate, and thymol in a suitable ointment base
Questions or Comments? Call toll-free 1-877-255-6999
Manufactured for:
Akron Pharma, Inc.
Fairfield, NJ 07004
www.akronpharma.com
This product is not manufactured or distributed by Calmoseptine Inc., owner of the registered trademark Calmoseptine.
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
HYDROSEPTINE
zinc oxide, menthol ointmentProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:71399-6743 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL 0.44 g in 100 g ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE 20.6 g in 100 g Inactive Ingredients Ingredient Name Strength FERRIC OXIDE RED (UNII: 1K09F3G675) CHLOROTHYMOL (UNII: LJ25TI0CVT) GLYCERIN (UNII: PDC6A3C0OX) LANOLIN (UNII: 7EV65EAW6H) PHENOL (UNII: 339NCG44TV) SODIUM BICARBONATE (UNII: 8MDF5V39QO) THYMOL (UNII: 3J50XA376E) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:71399-6743-1 100 g in 1 JAR; Type 0: Not a Combination Product 11/05/2021 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph final part346 11/05/2021 Labeler - AKRON PHARMA INC (067878881)